148 related articles for article (PubMed ID: 36857751)
1. A simple strategy for the efficient design of mitochondria-targeting NIR-II phototheranostics.
Li Y; He M; Liu Z; Chuah C; Tang Y; Duo Y; Tang BZ
J Mater Chem B; 2023 Mar; 11(12):2700-2705. PubMed ID: 36857751
[TBL] [Abstract][Full Text] [Related]
2. π Bridge Engineering-Boosted Dual Enhancement of Type-I Photodynamic and Photothermal Performance for Mitochondria-Targeting Multimodal Phototheranostics of Tumor.
Fang L; Meng Q; Zhang Y; Su R; Xing F; Yang H; Hou Y; Ma P; Huang K; Feng S
ACS Nano; 2023 Nov; 17(21):21553-21566. PubMed ID: 37910516
[TBL] [Abstract][Full Text] [Related]
3. A New Strategy to Elevate Absorptivity of AIEgens for Intensified NIR-II Emission and Synergized Multimodality Therapy.
Zhang J; Liu W; Liu Y; Zhang J; Gao P; Zheng L; Xu F; Jin G; Tang BZ
Adv Mater; 2023 Nov; 35(47):e2306616. PubMed ID: 37489377
[TBL] [Abstract][Full Text] [Related]
4. One-for-All Phototheranostic Agent Based on Aggregation-Induced Emission Characteristics for Multimodal Imaging-Guided Synergistic Photodynamic/Photothermal Cancer Therapy.
Liu L; Wang X; Wang LJ; Guo L; Li Y; Bai B; Fu F; Lu H; Zhao X
ACS Appl Mater Interfaces; 2021 May; 13(17):19668-19678. PubMed ID: 33896183
[TBL] [Abstract][Full Text] [Related]
5. A mitochondria-targeted molecular phototheranostic platform for NIR-II imaging-guided synergistic photothermal/photodynamic/immune therapy.
Yang S; Wu GL; Li N; Wang M; Wu P; He Y; Zhou W; Xiao H; Tan X; Tang L; Yang Q
J Nanobiotechnology; 2022 Nov; 20(1):475. PubMed ID: 36369039
[TBL] [Abstract][Full Text] [Related]
6. NIR-II Excitation Phototheranostic Nanomedicine for Fluorescence/Photoacoustic Tumor Imaging and Targeted Photothermal-Photonic Thermodynamic Therapy.
Dai Y; Zhao H; He K; Du W; Kong Y; Wang Z; Li M; Shen Q; Sun P; Fan Q
Small; 2021 Oct; 17(42):e2102527. PubMed ID: 34528387
[TBL] [Abstract][Full Text] [Related]
7. One-for-all phototheranostics: Single component AIE dots as multi-modality theranostic agent for fluorescence-photoacoustic imaging-guided synergistic cancer therapy.
Wen H; Zhang Z; Kang M; Li H; Xu W; Guo H; Li Y; Tan Y; Wen Z; Wu Q; Huang J; Xi L; Li K; Wang L; Wang D; Tang BZ
Biomaterials; 2021 Jul; 274():120892. PubMed ID: 34020267
[TBL] [Abstract][Full Text] [Related]
8. Natural-Origin Hypocrellin-HSA Assembly for Highly Efficient NIR Light-Responsive Phototheranostics against Hypoxic Tumors.
Zhang C; Wu J; Liu W; Zheng X; Wang P
ACS Appl Mater Interfaces; 2019 Dec; 11(48):44989-44998. PubMed ID: 31755268
[TBL] [Abstract][Full Text] [Related]
9. An All-Round Athlete on the Track of Phototheranostics: Subtly Regulating the Balance between Radiative and Nonradiative Decays for Multimodal Imaging-Guided Synergistic Therapy.
Zhang Z; Xu W; Kang M; Wen H; Guo H; Zhang P; Xi L; Li K; Wang L; Wang D; Tang BZ
Adv Mater; 2020 Sep; 32(36):e2003210. PubMed ID: 32696561
[TBL] [Abstract][Full Text] [Related]
10. Thiophene π-Bridge Manipulation of NIR-II AIEgens for Multimodal Tumor Phototheranostics.
Gui Y; Wang Y; Wang D; Qin Y; Song G; Yan D; Tang BZ; Wang D
Angew Chem Int Ed Engl; 2024 Apr; 63(14):e202318609. PubMed ID: 38345594
[TBL] [Abstract][Full Text] [Related]
11. NIR-II AIEgens with Photodynamic Effect for Advanced Theranostics.
Yin S; Song J; Liu D; Wang K; Qi J
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235186
[TBL] [Abstract][Full Text] [Related]
12. A-DA'D-A Structured Organic Phototheranostics for NIR-II Fluorescence/Photoacoustic Imaging-Guided Photothermal and Photodynamic Synergistic Therapy.
Yang K; Long F; Liu W; Zhang Z; Zhao S; Wang B; Zou Y; Lan M; Yuan J; Song X; Lin C
ACS Appl Mater Interfaces; 2022 Apr; 14(16):18043-18052. PubMed ID: 35420773
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Two-Photon AIE Luminogens for Highly Mitochondria-Specific Bioimaging and Efficient Photodynamic Therapy.
Zhuang W; Yang L; Ma B; Kong Q; Li G; Wang Y; Tang BZ
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20715-20724. PubMed ID: 31144501
[TBL] [Abstract][Full Text] [Related]
14. Fluorination Enhances NIR-II Emission and Photothermal Conversion Efficiency of Phototheranostic Agents for Imaging-Guided Cancer Therapy.
Li C; Jiang G; Yu J; Ji W; Liu L; Zhang P; Du J; Zhan C; Wang J; Tang BZ
Adv Mater; 2023 Jan; 35(3):e2208229. PubMed ID: 36300808
[TBL] [Abstract][Full Text] [Related]
15. Black SnO
Gao C; Guo W; Guo X; Ding Z; Ding Y; Shen XC
Acta Biomater; 2021 Jul; 129():220-234. PubMed ID: 34082106
[TBL] [Abstract][Full Text] [Related]
16. A Mitochondria-Targeted NIR-II Molecule Fluorophore for Precise Cancer Phototheranostics.
Zhao H; Chen K; Liu M; Wang Z; Li L; Li M; Sun P; Zhou H; Fan Q; Shen Q
J Med Chem; 2024 Jan; 67(1):467-478. PubMed ID: 38147641
[TBL] [Abstract][Full Text] [Related]
17. NIR-II Aggregation-Induced Emission Luminogens for Tumor Phototheranostics.
Tan Y; Liu P; Li D; Wang D; Tang BZ
Biosensors (Basel); 2022 Jan; 12(1):. PubMed ID: 35049674
[TBL] [Abstract][Full Text] [Related]
18. An NIR-II Excitable AIE Small Molecule with Multimodal Phototheranostic Features for Orthotopic Breast Cancer Treatment.
Song S; Zhao Y; Kang M; Zhang F; Wu Q; Niu N; Yang H; Wen H; Fu S; Li X; Zhang Z; Tang BZ; Wang D
Adv Mater; 2024 Apr; 36(14):e2309748. PubMed ID: 38165653
[TBL] [Abstract][Full Text] [Related]
19. Facile and green fabrication of tumor- and mitochondria-targeted AIEgen-protein nanoparticles for imaging-guided photodynamic cancer therapy.
Wang DP; Zheng J; Jiang FY; Wu LF; Wang MY; Wang YL; Qin CY; Ning JY; Cao JM; Zhou X
Acta Biomater; 2023 Sep; 168():551-564. PubMed ID: 37414113
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
